In summary, in this proof-of-concept study we have identified that inhibition of a miR-10a-5p can enhance CD8+ T cell cytotoxicity ex vivo in patients with chronic HIV-1 infection on long-term ART. The gene discussed is CD8A; the disease is HIV-1 infection.